High adherence and safety found in short TB treatments
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage…
Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…
Cognitive speed training shows potential to delay dementia for two decades
Adults age 65 and older who completed five to six weeks of cognitive speed training – in this…
Intense exercise proves more effective for panic disorder treatment
Panic attacks are sudden bouts of intense fear without an obvious cause. An estimated 10% of people experience…
Novel neuroprotective drug improves recovery after acute ischemic stroke
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48…
Daily coffee intake linked to fewer atrial fibrillation relapses
A randomized trial suggests that avoiding coffee after cardioversion may not help, and that modest caffeine intake may…
Eating beef as part of a healthy dietary pattern does not impact risk factors for type 2 diabetes
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D),…
Bacterial metabolite enhances immune checkpoint therapy against lung cancer
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response…
Implanted vagus nerve stimulation device offers lasting relief for severe depression
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a…
Real-time smartphone monitoring improves evaluation of insomnia treatment effectiveness
About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and…
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…
Women may derive greater long-term benefits from coronary artery bypass grafting compared with stents
Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits…